Fresh analysis reveals that people who discontinue new weight-loss injections like Wegovy and Mounjaro tend to recover reduced body mass at a significantly accelerated pace than those who stop conventional diet and exercise regimens.
Published data in a leading health publication demonstrates that while overweight individuals can lose substantial amounts of their body weight while using the jabs, the weight returns at an average rate of 0.8 kg per month after stopping.
"People buying such medications should be aware of the danger of fast weight regain when the medication is stopped," warns expert Dr. Susan Jebb.
This pace of recovery implies a reversion to pre-treatment mass in about a year and a half.
Weighing Approaches
The analysis, which reviewed dozens of studies involving over 9,000 of participants, compared the results of GLP-1 agonists with conventional dieting.
Scientists emphasize that individuals who shed pounds through lifestyle changes alone generally experience a more gradual creep back—perhaps 100 grams monthly—once they finish.
Explaining the Rapid Regain
Nutrition scientists believe the mode of action of the jabs accounts for the heightened regain.
GLP-1 drugs imitate a body's own chemical called glucagon-like peptide-1, which helps regulate feelings of fullness.
"Artificially providing GLP-1 concentrations far above than normal may cause the body to produce less of its own natural GLP-1, and may also reduce sensitivity to its actions," noted Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this hormone supplement leads to hunger is uncontrolled, making binge eating much more probable."
An Ongoing Condition?
Medical guidelines recommend the jabs for individuals with obesity-related medical conditions, alongside recommended diet and exercise modifications.
Many experts contend that, given the significant potential of relapse, the therapy might need to be ongoing.
This opinion is echoed by drug manufacturers, who note that the results "underscore the long-term character of excess weight," comparing it to managing conditions like diabetes.
User Testimonies
Users who have come off the jabs describe a intense resurgence of hunger.
"It felt as if something that goes on and I was suddenly ravenous," said a patient.
The struggle is compounded if users have not adopted lasting lifestyle or habit changes during treatment.
Widespread Use
Recent estimates suggest that millions of adults in the UK have tried these injections in the last 12 months, with demand continuing to grow.
- Use is greater among women than men.
- The middle-aged demographic shows the greatest usage rates.
- Many access the medications through private healthcare rather than the NHS.
Finally, researchers stress that while GLP-1 drugs are effective agents for shedding pounds, they are not a permanent fix and long-term success relies on integrated behavioural management.
